Better Health for All

Strata Skin Sciences' core products, including the XTRAC excimer laser and TheraClear®X Acne Therapy System, deliver exceptional health benefits by treating various dermatological conditions such as psoriasis, vitiligo, atopic dermatitis, and acne.

The XTRAC laser is noted for its superiority over other UVB light sources, offering deeper penetration and fewer epidermal side effects, with 92% of participants achieving a 75% or more reduction in mPASI score for plaque psoriasis. There is no evidence of revenue from products with established negative health outcomes. While products are described as safe and FDA-cleared, specific adverse event rates per million users are not provided, preventing a quantitative score for safety. The company's efforts to expand CPT codes for excimer laser treatment are expected to reduce systemic denials and prior authorizations, potentially increasing affordability and expanding coverage to over 30 million potential patients, including 3 million with vitiligo, 16.5 million with atopic dermatitis, and 4.6 million with alopecia areata. However, specific pricing relative to production cost or median income is not available. The company provides on-site training for practice personnel as part of its partnership program for the TheraClear®X system. During the COVID-19 pandemic, the company noted a potential shift to XTRAC treatment for immune-compromised patients, but this is not a direct crisis response action.

Fair Money & Economic Opportunity

Strata Skin Sciences, Inc. is a medical technology company focused on developing and commercializing products for dermatological conditions. Its core business involves selling medical devices and related services to healthcare providers. The company does not offer lending, insurance, deposit, or other financial services to consumers.

Therefore, the Key Performance Indicators under the 'Fair Money & Economic Opportunity' value, which are designed to assess financial institutions on aspects like consumer lending, pricing, fee structures, and financial inclusion initiatives, are not applicable to this company. No evidence was found in the provided articles that relates to the company's involvement in financial services or any of the specific metrics outlined in the rubric for this value.

Fair Pay & Worker Respect

The company's employee rating on Glassdoor is 2.5 out of 5 stars, which translates to an engagement score of 50/100.

Only 32% of employees would recommend working there, and 46% approve of the CEO. Compensation and benefits received a rating of 2.2 out of 5 stars. The company reports constant turnover in sales and has experienced layoffs. There have been zero fines or violations related to labor laws in the past two years.

Honest & Fair Business

The provided articles do not contain specific, quantifiable data points for any of the KPIs related to Honest & Fair Business practices for SSKN.US. While some articles mention the presence of a Whistleblower Policy and an Anti-Corruption Policy, they lack details on the strength, scope, or enforcement of these policies, which are necessary to map to specific score tiers in the rubric.

For all other KPIs, including regulatory fines, transparency index, financial restatements, audit coverage, ESG controversy, complaint resolution time, board conflict-free percentage, and third-party verification, the articles explicitly state that no data is available or were throttled, preventing data retrieval.

Kind to Animals

Strata Skin Sciences, Inc. is a medical technology company focused on dermatological devices.

For its XTRAC Momentum Excimer Laser System, no animal testing was performed during the FDA approval process. This is noted as standard for this type of medical device. Given the nature of the company's products, many animal welfare KPIs, such as those related to animal-derived ingredients, humane certifications for animal operations, or cage-free sourcing, are not applicable. No other specific data regarding the company's broader animal testing policies, R&D investment in animal-free technologies, or participation in animal welfare collaborations was provided.

No War, No Weapons

The provided article, which focuses on corporate governance, does not contain any specific, concrete data points or information relevant to Strata Skin Sciences, Inc.'s involvement in arms manufacturing, military contracts, dual-use technologies, peacebuilding initiatives, or any other criteria related to the 'No War, No Weapons' ethical value.

Consequently, no KPIs can be scored based on the evidence provided.

Planet-Friendly Business

Strata has set a target to achieve net-zero operational carbon for its offices and homes by 2030.

The company established a Carbon and Energy Working Group in 2023 and introduced electric vehicles to its company car scheme in 2021. It is also establishing a baseline for Scope 1, 2, and 3 emissions for FY 2023-24 using the Greenhouse Gas Protocol and RICS Whole Life Carbon Assessment.